1. Advances in the diagnosis and treatment of Von Willebrand disease
   Ruchika Sharma et al, 2017, Blood CrossRef
2. Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease
   H. P. Eising et al, 2018, Haemophilia CrossRef
3. Thrombin generation during a regular menstrual cycle in women with von Willebrand disease
   Igor Govorov et al, 2018, Sci Rep CrossRef
4. Advances in the diagnosis and treatment of Von Willebrand disease
   Ruchika Sharma et al, 2017, Hematology CrossRef
5. Women with inherited bleeding disorders – Challenges and strategies for improved care
   Keren O. Presky et al, 2019, Thrombosis Research CrossRef
6. Coagulopathy In and Outside the Intensive Care Unit
   Marie Bashaw et al, 2017, Critical Care Nursing Clinics of North America CrossRef
7. A Cross-Sectional Study of Women and Girls with Congenital Bleeding Disorders: The American Thrombosis and Hemostasis Network Cohort
   Kristina M. Haley et al, 2020, Journal of Women's Health CrossRef
8. Management of heavy menstrual bleeding on anticoagulation
   Bethany Samuelson Bannow, 2020 CrossRef
9. Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study
   Eva N. Hamulyák et al, 2020, Res Pract Thromb Haemost CrossRef
10. Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review
    Ateefa Chaudhury et al, 2020, Haemophilia CrossRef
11. Gynaecological issues in women with bleeding disorders: CSL Behring Symposium
    Angelika Batorova et al, 2019 CrossRef
12. von Willebrand disease: what does the future hold?
    Cécile V. Denis et al, 2021 CrossRef
13. Prophylactic management of patients with von Willebrand disease
    Massimo Franchini et al, 2021, Therapeutic Advances in Hematology CrossRef
14. Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature
    Romina Brignardello-Petersen et al, 2022 CrossRef
15. Patient‐reported outcomes in autosomal inherited bleeding disorders: A systematic literature review
    Evelien S. Hoorn et al, 2022, Haemophilia CrossRef
16. The lived experience of women with a bleeding disorder: A systematic review
    Anna Sanigorska et al, 2022, Res Pract Thromb Haemost CrossRef
17. Outcomes of long‐term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review
    Abdallah El Alayli et al, 2022, Haemophilia CrossRef
18. Towards novel treatment options in von Willebrand disease
    Peter J. Lenting et al, 2022, Haemophilia CrossRef
19. Defining the Impact of Social Drivers on Health Outcomes for People with Inherited Bleeding Disorders
    Karina Lopez et al, 2022, JCM CrossRef
20. Impact of von Willebrand Disease on Women's Health Outcomes: A Matched Cohort Database Study
    Katrina Wilcox Hagberg et al, 2022, Journal of Women's Health CrossRef
21. Gynaecological management of women with inherited bleeding disorders
    Nicola Curry et al, 2022, Haemophilia CrossRef
22. The Cost of Von Willebrand Disease in Europe: The CVESS Study
    George Morgan et al, 2022, Clin Appl Thromb Hemost CrossRef
23. Clinical, economic, and health‐related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews
    Giancarlo Castaman et al, 2022, Haemophilia CrossRef
24. Von Willebrand Disease—Specific Aspects in Women
    Fagr Eladly et al, 2022, Hamostaseologie CrossRef
25. Prognostic value of von Willebrand factor in clinical practice
    K. N. Grigoreva et al, 2022, Akušerstvo, ginekologiâ i reprodukciâ CrossRef
26. What have we learned about the patient's experience of von Willebrand disease? A focus on women
    Heather VanderMeulen et al, 2022 CrossRef
27. Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review
    Ping Du et al, 2023, JBM CrossRef
28. Burden of Illness and Treatment Patterns Among Patients With von Willebrand Disease in US Clinical Practice
    Elyse Swallow et al, 2023, Clin Appl Thromb Hemost CrossRef
29. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
    Margaret V Ragni et al, 2023, The Lancet Haematology CrossRef
30. Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies
    Miriam M. Moser et al, 2024, Semin Thromb Hemost CrossRef
31. von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
    Robert F. Sidonio et al, 2024 CrossRef
32. null
    Rezan Abdul Kadir, 2024 CrossRef
33. Women and girls with inherited bleeding disorders: Focus on haemophilia carriers and heavy menstrual bleeding
    Cedric Hermans et al, 2024, Haemophilia CrossRef
34. Tranexamic acid for management of heavy vaginal bleeding: barriers to access and myths surrounding its use
    Heather VanderMeulen et al, 2024, Research and Practice in Thrombosis and Haemostasis CrossRef